共 50 条
Temporal trends in mortality in patients with rheumatoid arthritis: a Danish population-based matched cohort study
被引:4
|作者:
Soussi, Bolette G.
[1
,2
,7
]
Duch, Kirsten
[1
]
Cordtz, Rene L.
[1
]
Lindhardsen, Jesper
[3
]
Kristensen, Salome
[1
,4
]
Bork, Christian S.
[5
]
Linauskas, Asta
[4
,6
]
Schmidt, Erik B.
[5
]
Dreyer, Lene
[1
,4
]
机构:
[1] Aalborg Univ Hosp, Ctr Rheumat Res Aalborg, Dept Rheumatol, Aalborg, Denmark
[2] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark
[3] Rigshospitalet, Ctr Rheumatol & Spine Dis, Lupus & Vasculitis Clin, Copenhagen, Denmark
[4] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
[5] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[6] North Denmark Reg Hosp, Dept Rheumatol, Hjorring, Denmark
[7] Aalborg Univ Hosp, Ctr Rheumat Res Aalborg CERRA, Dept Rheumatol, Reberbansgade 15, DK-9000 Aalborg, Denmark
关键词:
RA;
epidemiology;
pseudo-observation;
mortality;
prognosis;
outcome;
EXCESS MORTALITY;
SURVIVAL;
PREVALENCE;
D O I:
10.1093/rheumatology/kead325
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objectives To investigate the 5-year all-cause mortality in patients with RA compared with the general population. Methods This was a nationwide population-based matched cohort study. RA patients diagnosed between 1996 and the end of 2015 were identified using administrative heath registries and followed until the end of 2020 allowing 5 years of follow-up. Patients with incident RA were matched 1:5 on year of birth and sex with non-RA individuals from the Danish general population. Time-to-event analyses were performed using the pseudo-observation approach. Results Compared with matched controls in 1996-2000, the risk difference for RA patients ranged from 3.5% (95% CI 2.7%, 4.4%) in 1996-2000 to -1.6% (95% CI -2.3%, -1.0%) in 2011-15, and the relative risk from 1.3 (95% CI 1.2, 1.4) in 1996-2000 to 0.9 (95% CI 0.8, 0.9) in 2011-15. The age-adjusted 5-year cumulative incidence proportion of death for a 60-year-old RA patient decreased from 8.1% (95% CI 7.3%, 8.9%) when diagnosed in 1996-2000 to 2.9% (95% CI 2.3%, 3.5%) in 2011-15, and for matched controls from 4.6% (95% CI 4.2%, 4.9%) to 2.1% (95% CI 1.9%, 2.4%). Excess mortality persisted in women with RA throughout the study period, while the mortality risk for men with RA in 2011-15 was similar to their matched controls. Conclusions Enhanced improvement in mortality was found in RA patients compared with matched controls, but for sex-specific differences excess mortality was only persistent in women with RA.
引用
收藏
页码:1049 / 1057
页数:9
相关论文